‌

US Patent 11712485 Triazine based radiopharmaceuticals and radioimaging agents

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Molecular Insight Pharmaceuticals, Inc.

0

Current Assignee

Molecular Insight Pharmaceuticals, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

August 1, 2023

0

Patent Application Number

171298250

Date Filed

December 21, 2020

0

Patent Citations

US Patent 8926944 Radiolabeled prostate specific membrane antigen inhibitors

0

US Patent 9447121 Triazine based radiopharmaceuticals and radioimaging agents

0

US Patent 10086096 Triazine based radiopharmaceuticals and radioimaging agents

0

US Patent 10201624 Triazine based radiopharmaceuticals and radioimaging agents

0

US Patent 10898598 Triazine based radiopharmaceuticals and radioimaging agents

0

US Patent 7381745 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase

0

US Patent 7829065 CA IX-specific inhibitors

0

US Patent 8211402 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11712485 Triazine based radiopharmaceuticals and radioimaging agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.